Goncalo is a partner at Indaco Bio Fund. Goncalo has a PhD in Biochemistry from the Ludwig-Maximillian’s University in Munich, Germany and a MBA from MIT/Catholic University of Lisbon. He has more than 20 years of experience within the life science industry as a research scientist (10+ years), IP consultant (5+ years), and business developer for contract research and contract manufacturing organizations (10+ years). In 2015, Goncalo started Hovione Capital, an evergreen fund focusing on early-stage medtech and medical device opportunities across Europe and has held 10+ board roles. Prior to Indaco, Goncalo led the operational growth of Nanoform, from 20 to 146 people and was part of the management team that took the company public on the Nasdaq First North in 2021.